← Open Payments lookup

CASEY COPE: Open Payments

NPI 1073090528 · KANSAS CITY, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$648 in 43 payments from 16 companies in 2025. Trend: 2023 $425 · 2024 $717 · 2025 $648

Food & beverage: $648
CompanyPaymentsAmount
Novartis Pharmaceuticals Corporation14$176
Amgen Inc.12$143
Regeneron Healthcare Solutions, Inc.2$44
Bayer Healthcare Pharmaceuticals Inc.2$33
E.R. Squibb & Sons, L.L.C.2$33
Novo Nordisk Inc1$25
Boston Scientific Corporation1$24
Alnylam Pharmaceuticals Inc.1$24
Esperion Therapeutics, Inc.1$22
Baxter Healthcare1$21

Products named: LEQVIO, REPATHA, DUPIXENT, Kerendia, CAMZYOS, Ozempic, WATCHMAN FLX, AMVUTTRA.

Industry payments across MO — which companies pay providers there.